News related to Combivent (Ipratropium / Albuterol) and/or conditions it is approved for
Chronic Obstructive Pulmonary Disease
Source: MedicineNet Alpha 1 Antitrypsin Deficiency Specialty [2013.05.13]
Title: Chronic Obstructive Pulmonary Disease
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 5/13/2013 12:00:00 AM
COPD (Chronic Obstructive Pulmonary Disease) Quiz
Source: MedicineNet albuterol Specialty [2012.11.06]
Title: COPD (Chronic Obstructive Pulmonary Disease) Quiz
Category: MedicineNet Quiz
Created: 10/8/2012 5:18:00 PM
Last Editorial Review: 11/6/2012 5:24:02 PM
COPD Foods Pictures Slideshow: Energy-Boosting Foods for Chronic Obstructive Pulmonary Disease
Source: MedicineNet Pneumothorax Specialty [2011.09.14]
Title: COPD Foods Pictures Slideshow: Energy-Boosting Foods for Chronic Obstructive Pulmonary Disease
Category: Slideshows
Created: 6/18/2010 12:20:00 PM
Last Editorial Review: 9/14/2011 12:00:00 AM
Respiratory Symptoms And Exacerbations In COPD Worsened By Allergic Disease
Source: Allergy News From Medical News Today [2013.05.14]
Patients with chronic obstructive pulmonary disease (COPD) who also have allergic disease have higher levels of respiratory symptoms and are at higher risk for COPD exacerbations, according to a new study from researchers at Johns Hopkins University in Baltimore...
New Inhaler Drug Approved By FDA For Chronic COPD
Source: Respiratory / Asthma News From Medical News Today [2013.05.12]
The U.S. Food and Drug Administration has just announced the approval of a form of new long-term treatment for patients suffering from chronic obstructive pulmonary disease (COPD). The new treatment is an inhaler drug called Breo Ellipta (fluticasone furoate and vilanterol inhalation powder). It is also approved for the treatment of exacerbations in COPD patients...
Allergic Disease Worsens Respiratory Symptoms And Exacerbations In COPD
Source: Allergy News From Medical News Today [2013.05.10]
Patients with chronic obstructive pulmonary disease (COPD) who also have allergic disease have higher levels of respiratory symptoms and are at higher risk for COPD exacerbations, according to a new study from researchers at Johns Hopkins University in Baltimore...
FDA Approves Once-Daily COPD Drug
Source: MedPage Today Allergy & Immunology [2013.05.10]
(MedPage Today) -- SILVER SPRING, Md. -- The FDA has given the green light to the novel, inhaled drug Breo Ellipta to treat chronic obstructive pulmonary disease.
FDA Panel Backs Once-Daily COPD Drug
Source: MedPage Today Allergy & Immunology [2013.04.17]
(MedPage Today) -- SILVER SPRING, Md. -- A novel, once-daily inhaled drug to treat chronic obstructive pulmonary disease received the backing of an FDA advisory committee Wednesday.
Lives Could Be Saved By Drugs That Limit Excess Mucus
Source: Cystic Fibrosis News From Medical News Today [2012.11.28]
Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease (COPD) are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions - excess mucus production. "There is good evidence that what kills people with severe COPD or asthma is mucus obstructing the airway," says Michael J...
|
